1-4 of 4
Yingmei Li
Close
Sort by
Journal Articles

Iron Chelation of Hetrombopag in Aplastic Anemia: A Post Hoc Analysis of a Phase II Study

Wenrui Yang, Xin Zhao, Guangsheng He, Hong Chang, Bing Han, Sujun Gao, Shunqing Wang, Tong Chen, Fei Li, Yi Wang, Xiaoyan Ge, Rong Fu, Zheng Ge, Yingmei Li, Hong Liu, Xinjian Liu, Miao Miao, Liansheng Zhang, Fengkui Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 5809–5810.
https://doi.org/10.1182/blood-2022-164560
Published: 2022
Journal Articles

A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)

Fengkui Zhang, Guangxin Peng, Guangsheng He, MD PhD, Hong Chang, Sujun Gao, Xinjian Liu, Tong Chen, MD PhD, Pei Li, Bing Han, Miao Miao, Zheng Ge, MDPhD, Xiaoyan Ge, Fei Li, Yingmei Li, Shunqing Wang, Yi Wang, MD, Yaqi Shen, Yanfei Tai, Tao Zhang, Bo Zhu, Jianjun Zou
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-137319
Published: 2020
Journal Articles

Real-World Effectiveness and Safety of Eltrombopag in Patients with Aplastic Anemia: A Chinese Nationwide Survey

Wenrui Yang, MD, Bing Han, MD PhD, Hong Chang, MD, Bingyi Wu, MD, Fankai Meng, Dexiang Ji, MD, Yingmei Li, MD, Zhengjin Zheng, MD, Yan Fei, Jianping Shen, MD, Ping Hu, MD, Jianxiang Wang, MD, Fengkui Zhang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5020.
https://doi.org/10.1182/blood-2019-126441
Published: 2019
Journal Articles

Clinical Characteristics and Outcome of Biphenotypic Acute Leukemia: 10 Cases Report and Literature Review

Jifeng Yu, MD, Yingmei Li, MD, Haizhou Xing, Hui Sun, Dingming Wan, MD, Yanfang Liu, Xinsheng Xie, MD, Chong Wang, Ling Sun, MD PhD, Kai Sun, MD, Zhongxing Jiang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5207.
https://doi.org/10.1182/blood-2019-127580
Published: 2019